NCT03595761

Brief Summary

Purulent meningitis are life-threatening diseases in childhood. Cerebral vasculitis have been described in bacterial meningitis, but poor is known about their physiology and their impact on outcome. The investigators decide to realize a retrospective mono-centric study carried out at Montpellier university hospital which looks back at a 7-year study(2009-2016). The Investigators selected purulent meningitis cases based on the bacteriological data provided by the HDB (hospital data base). The Investigators divides in two groups : Group A if patients present a cerebral vasculitis ( radiologic diagnostic by RMI or tomodensitometry), in all, cases the diagnosis of vasculitis was confirmed by a radiologist specialised in neuropaediatrics by a second reading;Group B purulent meningitis with a cerebral vasculitis imaging. Tuberculous meningitis, meningitis in CSF shunt, and in patients having chemotherapy were excluded. The investigators report clinical and biological finding, inflammatory marker at the onset. The Investigators register also the clinical evolution and sequelae

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 6, 2017

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
11 months until next milestone

First Posted

Study publicly available on registry

July 23, 2018

Completed
Last Updated

July 26, 2018

Status Verified

July 1, 2017

Enrollment Period

2 months

First QC Date

July 6, 2017

Last Update Submit

July 23, 2018

Conditions

Keywords

cerebral vasculitis

Outcome Measures

Primary Outcomes (5)

  • Found a difference demographic data

    Found a difference demographic data between population A and B (age)

    1 day

  • Found a difference demographic data

    Found a difference demographic data between population A and B (gender)

    1 day

  • Found a difference Clinical manifestation

    Found a difference Clinical manifestation between population A and B

    1 day

  • Found a difference Inflammatory parkers

    Found a difference Inflammatory parkers between population A and B

    1 day

  • Found a difference Infectious agent

    Found a difference Infectious agent between population A and B

    1 day

Secondary Outcomes (2)

  • Found a difference in the evolution of the diseases between group A and B

    1 day

  • In the A group, studying the relationship between prescription of steroids pulse and final outcome and presence of sequelae.

    1 day

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children with bacterial meningitis, and cerrbal vasculitis

You may qualify if:

  • bacterial meningitis with LCR confirmation

You may not qualify if:

  • tuberculous meningitis, immunosuppressor treatment, material like DVP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34290, France

Location

MeSH Terms

Conditions

Meningitis, BacterialVasculitis, Central Nervous System

Condition Hierarchy (Ancestors)

Central Nervous System Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsCentral Nervous System InfectionsCentral Nervous System DiseasesNervous System DiseasesMeningitisNeuroinflammatory DiseasesAutoimmune Diseases of the Nervous SystemCerebrovascular DisordersBrain DiseasesVascular DiseasesCardiovascular DiseasesVasculitisAutoimmune DiseasesImmune System Diseases

Study Officials

  • Eric JEZIORSKI

    UH

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2017

First Posted

July 23, 2018

Study Start

June 1, 2017

Primary Completion

August 1, 2017

Study Completion

August 31, 2017

Last Updated

July 26, 2018

Record last verified: 2017-07

Locations